Indeed, it is possible that in cancer cells, the oncogenic transcription factors use ATAD2 to facilitate their action on chromatin and the resulting malignant transformation would impose a privileged direct or indirect interaction between these factors and ATAD2. This evidence concerns the gene ATAD2 and cancer.